-
The Centers for Medicare and Medicaid Services is creating an infection control inspection survey for hospitals as part of its participation in the recently formed Partnership for Patients.
-
There has been so much hoopla about driving central line-associated bloodstream infections (CLABSIs) down to zero with checklists and bundles, that a unit that fails to achieve such success may take it somewhat personal.
-
UTIs have been termed the Rodney Dangerfield of infections, out of a skewed perception that they are easy to treat and have relatively little clinical consequence.
-
Elders who ate sorbet before a meal ate more of the rest of their meal.
-
A very low energy diet followed by a weight maintenance program results in significant improvements in weight, obstructive sleep apnea, metabolic factors, and quality for at least a year.
-
A second NS3/4A protease inhibitor has been approved by the FDA for the treatment of chronic hepatitis C (HCV) genotype 1, joining the recently approved boceprevir (Victrelis). Telaprevir is marketed by Vertex Pharmaceuticals as Incivek.
-
-
Proton pump inhibitor use in clopidogrel-treated post-percutaneous coronary intervention patients was not associated with an increased risk of all-cause death, nonfatal myocardial infarction, repeat revascularization, or major adverse cardiovascular events.
-
-
In May of this year, German public health authorities reported a significant increase in the number of patients with diarrhea caused by a Shiga toxin-producing Escherichia coli (STEC), as well as of cases of hemolytic uremic syndrome (HUS).